Biogen
BIIB
#431
Rank
$39.01 B
Marketcap
$270.03
Share price
1.83%
Change (1 day)
27.57%
Change (1 year)

Biogen is an American biotech company based in Cambridge, Massachusetts. The company uses recombinant DNA technology, also known as biotechnology. This makes it possible to produce human proteins and therefore medicinal products with the help of microorganisms. The company continues to develop new substances and works on improving already approved molecules.

EPS for Biogen (BIIB)

EPS in 2022 (TTM): $20.99

According to Biogen's latest financial reports the company's current EPS (TTM) is $20.99. In 2021 the company made an earnings per share (EPS) of $10.43 a decrease over its 2020 EPS that were of $24.50.

EPS history for Biogen from 2011 to 2022

Annual EPS

Year EPS Change
2022 (TTM)$20.99101.25%
2021$10.43-57.43%
2020$24.50-22.27%
2019$31.5245.66%
2018$21.6481.39%
2017$11.93-29.62%
2016$16.9510.28%
2015$15.3723.65%
2014$12.4357.94%
2013$7.8735.92%
2012$5.7913.53%
2011$5.10

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$7.29-65.27%๐Ÿ‡บ๐Ÿ‡ธ USA
$5.31-74.70%๐Ÿ‡บ๐Ÿ‡ธ USA
$6.69-68.11%๐Ÿ‡บ๐Ÿ‡ธ USA
$12.54-40.26%๐Ÿ‡บ๐Ÿ‡ธ USA
$3.30-84.29%๐Ÿ‡ซ๐Ÿ‡ท France
$2.66-87.33%๐Ÿ‡บ๐Ÿ‡ธ USA
-$26.39-225.73%๐Ÿ‡บ๐Ÿ‡ธ USA
-$6.93-133.02%๐Ÿ‡บ๐Ÿ‡ธ USA
$1.85-91.19%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
-$121.32-677.99%๐Ÿ‡บ๐Ÿ‡ธ USA